MarketInOut Stock Screener Log In | Sign Up
 

Indivior Pharmaceuticals Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/01/2026 16:00
Indivior Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,353.02 mln
Float99.31 mln
Earnings Date10/29/2026

EPS

2.79
Solid

P / E

12.68
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.63
Highly suspicious

Relative Strength

56 / 100
Slightly ahead

Pre-Tax Margin

30%
Strong margin

Business Description

Indivior Pharmaceuticals is a global specialty pharmaceutical company focused on helping people recover from opioid addiction and related conditions. Its main products are SUBLOCADE, a once-monthly injectable, and SUBOXONE Film, both of which contain buprenorphine and are widely used to treat opioid use disorder across the United States, Europe, Canada, Australia, and other markets. The company is also working to expand its treatment options through several drugs in clinical development. Headquartered in North Chesterfield, Virginia, Indivior has been operating since 2014.

Key Fundamentals

EPS2.79
P/E12.68
ROE-216
RPS10.78
ROIC62.70
ROA27.31
Interest Cover15.67
EBITDA, mln437
EV / EBITDA10.07
EV / EBIT10.48
Revenue, mln1,332
EV / Revenue3.30

Quote Details

Last 35.38
Change -0.47 (-1.31%)
Open 35.85
Volume 894,923
Turnover 31,662,376
Average Volume 1,561,471

Financial Ratios

Pre-Tax Profit Margin30
Current Ratio0.84
Price / Sales3.36

Financial Strength

Altman Z-Score3.4
Piotroski F-Score 5 / 9
Beneish M-Score-0.63
Shiller PE Ratio54.42
Short Ratio5.60
Short % of Float11.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.72% 36 / 100   
1 Month 2.37% 79 / 100   
2 Months -14.31% 23 / 100   
6 Months 15.43% 75 / 100   
1 Year 46.74% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us